Developing new treatments to combat bacterial resistance using biopharmaceuticals
Official title: Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
Funded at American Type Culture Collection · NIH-10934750 · Data updated 2026-11-12
This study is working on new treatments to help fight infections caused by bacteria that don't respond to regular medicines, and it aims to create better therapies for patients who need them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | American Type Culture Collection NIH-funded |
| Lab location | 1 site (Manassas, United States) |
| Project start | September 8, 2023 |
| Project end | September 7, 2030 |
| Funding year | 2023 |
| Award (this year) | $1,458 |
| NIH project number | 75N93023D00009-0-759302300002-1 |
| Project ID | NIH-10934750 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals suffering from infections that are resistant to current antibiotic treatments.
✕Less likely to help
Patients with infections that are not caused by bacterial pathogens or those who do not have antibiotic-resistant infections may not benefit from this research.
What this research studies
This research focuses on the preclinical development of innovative biopharmaceutical products aimed at addressing bacterial drug resistance. It utilizes advanced biotechnology processes to create materials such as monoclonal antibodies, recombinant proteins, and small interfering RNA (siRNA) vectors. The program includes comprehensive services like product development planning, assay development, and regulatory support to ensure effective translation of these products into clinical applications for infectious diseases. Patients may benefit from new therapies that emerge from this research as it progresses through the development pipeline.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for infections caused by antibiotic-resistant bacteria.
How similar studies have gone: Other research in the field of biopharmaceuticals has shown promise in developing effective treatments for bacterial resistance, indicating that this approach has potential for success.
Where this research is happening
-
American Type Culture Collection
Manassas, United States Active
Related research
Other NIH-funded projects on the same topics.
-
Collection and distribution of infectious disease research materials
This study is all about making sure scientists have the best tools and materials they need to learn more about infectious diseases and develop new treatments, so they can help people stay healthy.
-
Collection and distribution of infectious disease resources to combat antibiotic resistance
This study is all about helping scientists get the right tools and materials they need to better understand and fight infections and antibiotic resistance, so they can develop better treatments for everyone.
-
Developing models to understand infectious diseases.
This study is all about building models that mimic infectious diseases so researchers can learn more about how they work and find better treatments, which could help patients like you in the future.
-
Developing models to understand infectious diseases.
This study is working on building models that mimic infectious diseases to help us learn more about how they work and find better treatments, which could lead to new options for patients dealing with these illnesses.
-
Developing models to understand infectious diseases.
This study is all about creating models that mimic infectious diseases so researchers can better understand how they work and find new treatments that could help patients like you in the future.
-
Developing new biopharmaceutical products for infectious diseases
This study is working on improving new treatments for infectious diseases, like vaccines and medicines, to help patients get better faster and more effectively.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.